Provides secured loans to venture capital-backed companies. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.
This company is not turning a profit, so the market is pricing its sales instead: 5.8× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 98% of them.
No analyst target is on record for this company.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
The price looks reasonable next to what the company earns.
Clearly below the class average.
The price is looking for direction — no strong breakout, no collapse.
Growth: Sales growth trails the sector average.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $40.0M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 16 buys and 0 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.56 per share each year — regular cash for whoever holds the stock.
A loss of $2.7M against $40.0M in annual sales.
The growth engine is running at low revs right now. Report-card grade: 38/100.
The price action doesn’t yet back an upward turn.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.